Promote Sponsor
verified SJR 0,717 · Q1 • database Scopus / SJR & Web of Science indexed
ChemMedChem
United Kingdom · John Wiley and Sons Ltd
workspace_premium Q1 — Biochemistry lock Subscription Unclaimed

ChemMedChem

ChemMedChem is a journal indexed in SJR in Biochemistry and Drug Discovery with an H index of 123. It has a price of 2040 €. It has an SJR impact factor of 0,717 and it has a best quartile of Q1. It has an SJR impact factor of 0,717.

ChemMedChem focuses its scope in these topics and keywords: inhibitors, drug, chemmedchem, chemistry, activity, analogues, human, molecules, medicinal, ligands, ...

ISSN: 1860-7179
Editorial: John Wiley and Sons Ltd
Category: Biochemistry
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
0,717 Q1
H-index 123
Tasa de Aceptación pie_chart
24% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
2.040 € Subscription
Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,717

H-index

123

Docs (year)

313

Docs 3y

810

Total refs

20699

Cites 3y

2849

Citable 3y

801

Cites/Doc 2y

3.31

Ref/Doc

66.13

Immediate OA

2040 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cationic Branched Polyethylenimine (BPEI) Disables Antibiotic Resistance in Methicillin-Resistant Staphylococcus epidermidis

View more

Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors-What Some May Have Forgotten or Would Rather Forget?

View more

Design and Synthesis of Novel Cyclooxygenase-1 Inhibitors as Analgesics: 5-Amino-2-ethoxy-N-(substituted-phenyl)benzamides

View more

Design and Synthesis of N-Acylated Aza-Goniothalamin Derivatives and Evaluation of Their in vitro and in vivo Antitumor Activity

View more

Design and Synthesis of 4-(2,4,5-Trifluorophenyl)butane-1,3-diamines as Dipeptidyl Peptidase IV Inhibitors

View more

Cover Picture: Molecular Assembly of Multifunctional 99mTc Radiopharmaceuticals Using "Clickable" Amino Acid Derivatives (ChemMedChem 12/2010)

View more

Cover Picture: Characterization of C-Alkyl Amidines as Bioavailable Covalent Reversible Inhibitors of Human DDAH-1 (ChemMedChem 1/2011)

View more

Conjugation of ATIII-Binding Pentasaccharides to Extend the Half-Life of Proteins: Long-Acting Insulin

View more

Comparative Molecular Profiling of the PPARa/ gamma Activator Aleglitazar: PPAR Selectivity, Activity and Interaction with Cofactors

View more

Combating Cystic Fibrosis: In Search for CF Transmembrane Conductance Regulator (CFTR) Modulators

View more

Chemistry, Biology, and QSAR Studies of Substituted Biaryl Hydroxamates and Mercaptoacetamides as HDAC Inhibitors - Nanomolar-Potency Inhibitors of Pancreatic Cancer Cell Growth

View more
SHOW MORE ARTICLES

Chemical Synthesis and Biological Evaluation of the Englerin Analogues

View more

(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1AReceptor Agonist

View more

Authors Profile

View more

Asymmetric Synthesis and Conformational Analysis by NMR Spectroscopy and MD of Aba- and a-MeAba-Containing Dermorphin Analogues

View more

Assessment of Bromodomain Target Engagement by a Series of BI2536 Analogues with Miniaturized BET-BRET

View more

Antiproliferative Effects of Ester- and Amide-Functionalized Rhizoxin Derivatives

View more

Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations

View more

An Efficient Bioorthogonal Strategy Using CuAAC Click Chemistry for Radiofluorinations of SNEW Peptides and the Role of Copper Depletion

View more

Allosteric Inhibitor Development Targeting HIV-1 Integrase

View more

A Versatile and Practical Synthesis toward the Development of Novel HIV-1 Integrase Inhibitors

View more

A Synthetic C34 Trimer of HIV-1 gp41 Shows Significant Increase in Inhibition Potency

View more

A Potent Integrin Antagonist from a Small Library of Cyclic RGD Pentapeptide Mimics Including Benzyl-Substituted Azabicycloalkane Amino Acids

View more

FAQS